Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

JAMA ◽  
1995 ◽  
Vol 273 (3) ◽  
pp. 199-208 ◽  
Sign in / Sign up

Export Citation Format

Share Document